Literature DB >> 8213865

Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome.

C J Fichtenbaum1, L R Peterson, G J Weil.   

Abstract

OBJECTIVE: To describe clinical and laboratory features of patients with severe ehrlichiosis, some of whom presented with toxic shock syndrome (TSS)-like illnesses, and to report, to our knowledge, the first documented fatal case of ehrlichiosis in a child.
DESIGN: Case series.
SETTING: Tertiary-care medical center. PATIENTS: All patients with documented ehrlichiosis during a 3-year period, August 1, 1989, to July 31, 1992.
RESULTS: Eight patients (age range: 2 to 46 years) met clinical and serologic diagnostic criteria for ehrlichiosis. The mean interval from first contact with a physician to initiation of appropriate antibiotic therapy was 4.6 days (range: 1 to 11 days). All eight patients with ehrlichiosis had fever, chills, thrombocytopenia, and abnormal liver function test results. Most patients also had rash (seven), conjunctival hemorrhage or erythema (six), and leukopenia (six). Four cases met diagnostic criteria for TSS with fever, hypotension, rash, and multiorgan dysfunction. Two patients required mechanical ventilation, and one of these, a 6 1/2-year-old boy, died of complications of the infection. A ninth patient with probable ehrlichiosis also met diagnostic criteria for TSS.
CONCLUSIONS: Human ehrlichiosis can present as a severe, life-threatening illness that may resemble TSS. The diagnosis of ehrlichiosis was not considered by the physicians who first cared for these patients. Greater awareness of the potential severity of ehrlichiosis is needed to ensure that proper treatment is initiated early in the course of the disease.

Entities:  

Mesh:

Year:  1993        PMID: 8213865     DOI: 10.1016/0002-9343(93)90302-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

3.  Renal, hepatic, and marrow dysfunction in a patient with chronic renal insufficiency.

Authors:  Rebecca C Brady; John J Bissler
Journal:  Pediatr Nephrol       Date:  2003-02-12       Impact factor: 3.714

4.  Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.

Authors:  C D Paddock; J W Sumner; G M Shore; D C Bartley; R C Elie; J G McQuade; C R Martin; C S Goldsmith; J E Childs
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

6.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

7.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

Review 8.  Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

Authors:  Nasia Safdar; Robert B Love; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

9.  MyD88-dependent signaling contributes to host defense against ehrlichial infection.

Authors:  Young-Sang Koh; Jung-Eun Koo; Amlan Biswas; Koichi S Kobayashi
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.

Authors:  Qin Yang; Purnima Ghose; Nahed Ismail
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.